Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1

Status

Completed 16Recruiting 5Terminated 4Unknown 3Not yet recruiting 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 3Gynecologic 2

Conditions

Colorectal Neoplasms 77Carcinoma, Hepatocellular 48Ovarian Neoplasms 41Carcinoma, Non-Small-Cell Lung 26Neoplasms 22Fallopian Tube Neoplasms 17Lung Neoplasms 15Breast Neoplasms 13Neoplasm Metastasis 12Glioblastoma 12Endometrial Neoplasms 12Colonic Neoplasms 11Brain Neoplasms 11Uterine Cervical Neoplasms 10Triple Negative Breast Neoplasms 10Rectal Neoplasms 10Liver Neoplasms 9Stomach Neoplasms 8Colorectal Cancer Metastatic 7Pancreatic Neoplasms 6Advanced Solid Tumors 6Recurrence 5Melanoma 5Glioma 5Carcinoma, Renal Cell 5Carcinoma, Ovarian Epithelial 5Biliary Tract Neoplasms 5Solid Tumor 4Meningeal Carcinomatosis 4Adenocarcinoma of Lung 4

Interventions

Cyclophosphamide 21venetoclax 18pembrolizumab 16Dexamethasone 16fludarabine 14Cytarabine 13Gemcitabine 9pomalidomide 8Rituximab 8Carboplatin 8Azacitidine 8glofitamab 7fludarabine phosphate 7Lenalidomide 7Immunotherapy, Adoptive 7selinexor 6Paclitaxel 6Injections 6Granulocyte Colony-Stimulating Factor 6Cisplatin 6daratumumab 5Temozolomide 5Oxaliplatin 5Bevacizumab 5zanubrutinib 4ruxolitinib 4Surgical Procedures, Operative 4Nivolumab 4Drug Therapy 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Recurrence × Bevacizumab × Clear all
NCT07340164 2026-04-20

TROY

Yonsei University

Phase 2 Recruiting
116 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting
232 enrolled
CNS

Ependymoma, Medulloblastoma, Recurrence

NCT07263438 2026-02-13

Phenix

Centre Hospitalier Universitaire Vaudois

Phase 2 Recruiting
59 enrolled
CNS

Glioblastoma, Recurrence

NCT06859775 2025-06-06

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 1/2 Recruiting
100 enrolled
Gynecologic

Uterine Cervical Neoplasms, Recurrence

NCT06801730 2025-01-30

NALIRIBVRG

The Central Hospital of Lishui City

Phase 2 Recruiting
38 enrolled
CNS

Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡